Online Certificate Course on IPR and Pharmaceutical R&D (CCIPR)

Federation of Indian Chambers of Commerce and Industry (FICCI) is conducting an Online Certificate Course on IPR and Pharmaceutical R&D (CCIPR). The objective of the Course is to provide the platform to understand the working of pharmaceutical industry, its business models, research, regulatory aspects and its relevance with respect to intellectual property rights.

The duration of the online Course is 6 months and would be conducted twice a year.

This is first of its kind of course introduced with specific focus on the interlinking between the pharmaceutical industry and IPR.

Last date of Registration is 25th October 2012.

The Course may be pursued by the any student in pharmacy/ pharmaceutical sciences or industry persons working in the pharmaceutical sector, willing to enter Pharmaceutical R&D, Formulations, Generics, NDDS, Regulatory affairs, Drug discovery, Clinical research, Toxicology, International Business, Business strategy, Strategic planning and the like.

Website: www.ficciipcourse.in

Advertisements

Master’s in Intellectual Property Law :Opportunities

Indira Gandhi National Open University (IGNOU), School of Law , in association with Queensland University of Technology (QUT), Australia has launched a first of its kind Master’s Programme in Intellectual Property Law (MIPL). A two year Master’s programme which is India’s only Master’s programme in Intellectual Property law, shall be delivered and managed by Rainmaker, India’s leading solutions provider to the Legal industry, through its proprietary online learning platform, eMentor.
MIPL programme has been designed by an Expert Committee conmprising of leading academicians from the IGNOU-School of Law panel and others such as Professor Kamal Puri from the QUT, who have established international reputations in the field. In addition, leading practitioners, such as Rodney Ryder, form part of the panel of experts contributing to the programme.
The programme is delivered completely online, and, is open to graduates from all streams. It has been designed to suit the learning needs of both legally qualified and “non-legal” professionals, and aims to provide an in-depth examination of both classical and contemporary areas of, and developments in, Intellectual Property law.
The MIPL programme is delivered using virtual-learning friendly components such as self-instructional text, audio-video materials, radio and television broadcasts, online counselling, video-conferencing, and other innovative internet-based learning techniques and systems.
The next batch of the programme commences on March 1,2010.
Registration shall continue till March 31,2010.
The programme fee is Rs.36,000/- which can be paid in two installments.
For more details ,please see here.
To download the programme brochure,click here.

Patenting Public-Funded Research for Technology Transfer

ICRIER Working Paper No. 244

Patenting Public-Funded Research for Technology Transfer: A Conceptual-Empirical Synthesis of US Evidence and Lessons for India

January 2010

by

Amit Shovon Ray

Sabyasachi Saha

The question of protecting intellectual property rights by academic inventors was never seriously contemplated until the introduction of the Bayh-Dole Act in 1980 in the US. The Act allowed universities to retain patent rights over inventions arising out of federally-funded research and to license those patents exclusively or non-exclusively at their discretion. This particular legislation was a response to the growing concern over the fact that federally funded inventions in the US were not reaching the market place. In this paper, we present a critical review of the US experience after the Bayh-Dole Act and argue that the evidence is far from being unambiguous. We discuss the debate surrounding the Act – the extent to which it was successful in achieving its objectives, the unintended consequences, if any, and more generally, the effectiveness of IPR as a vehicle of technology transfer from universities. We also discuss the limited evidence on Bayh-Dole type legislations introduced in other countries. A new legislation, along the lines of the US Bayh-Dole Act – The Protection and Utilisation of Public Funded IP Bill, 2008 – is presently before the Indian parliament. The paper presents an Indian perspective against the backdrop of the US experience in an attempt to draw concrete lessons for India.

Abstract File | Full Text in PDF

Glaxo to share malaria drug data

Pharmaceutical giant GlaxoSmithKline (GSK) will release 13,500 malaria drug candidates into the public domain as part of its ‘open innovation’ agenda, it announced on 20 January 2010.

Chief executive Andrew Witty outlined the company’s strategy for increasing its intellectual property flexibility and altering its business model to tackle neglected tropical diseases.

“We’re trying to identify a more pluralistic approach to how we might solve very difficult problems,” he said.

“We need to be much more … open minded and be prepared to try new things,” Witty told a meeting at the New York Academy of Sciences, United States.

Under the plans any researcher or company will have access to the chemical structures of and associated data about more than 13,500 compounds shown to have activity against Plasmodium falciparum, the most dangerous malaria parasite. They would be free to use this information provided they were working towards tackling malaria in least developed countries.

Five GSK scientists screened their two-million-compound library by hand to find the shortlist.

The company will also create an ‘open lab’ at its neglected diseases research and development (R&D) facility in Spain. There, up to 60 researchers will be able to use GSK infrastructure and expertise to carry out their own neglected disease research projects, with the company providing a total of US$8 million in seed funding.

Ian Boulton of TropMed Pharma Consulting, which works with the pharmaceutical industry on expanding neglected diseases R&D, described the open lab initiative as “groundbreaking” and hoped other companies active in the malaria field, such as Novartis and Sanofi Aventis, would follow suit.

But he said: “Drug discovery is a long process and both the organisations involved and GSK need to have worked out how the projects can be carried forward once their time in the ‘open lab’ is over”.

“The malaria community needs to develop a system to use this data in an intelligent manner. It would be a shame if there was no coordination or information sharing on who will be working on what classes of compounds,” he added.

Mohga Kamal-Yanni, a senior health policy adviser at Oxfam, said: “This action is going beyond their own R&D decisions to encourage others. They have gone further than opening libraries, by actually doing the screening themselves.”

Witty said that GSK is committed to continuing malaria R&D. “We have five or six malaria compounds in clinical or preclinical testing.”

Last year GSK announced it would allow royalty-free access to its patents and knowhow on drugs for neglected diseases (see Glaxo patent rethink sparks debate), as well as ploughing 20 per cent of profits made in least developed countries back into their health systems and cutting drug prices.

However, no other drug company joined the patent pool.

Source: SciDev.Net

Online Certifications from WIPO Worldwide Academy

WIPO Worldwide Academy offers following Online Certifications

* General Course on Intellectual Property (DL-101) [March 1 to April 19, 2010]
Summary: This course covers the main areas of intellectual property, namely copyright, related rights, patents, trademarks, geographical indications, industrial design, plant breeders’ rights, unfair competition and international registration systems.

* Patent Information Search (DL-318E) [March 11 to May 19, 2010]
Summary: The intention of this distance learning course relating to patent information searching is to introduce you to, and illustrate the concepts, of searching patent information.

* Arbitration and Mediation Procedure under the WIPO Rules (DL-317E) [March 16 to April 27, 2010]
Summary: This advanced course is intended to describe the main features and advantages of the procedures designed by the WIPO Arbitration and Mediation Center; how the selection process of the most appropriate dispute resolution procedure for any given case; and how to draft appropriate dispute resolution clauses for insertion into and agreement.

* Trademarks, Industrial Designs and Geographical Indications (DL-302E) [March 10 to May 18, 2010]
Summary: This advanced course is intended to provide training material online to cover intellectual property aspects which are closely related to trade and competition in the globablized market. Additionally, the course is intended to educate and raise awareness of some of the complex issues that surround the protection and management of intellectual property for branding.

* Patents (DL-301E) [March 9 to May 17, 2010]
Summary: This advanced course is intended to explain the basic principles of patents, their economic impact, the process of patenting, describe technology transfer, patent pool and the traditional use of patents by centers of knowledge such as universities. It covers the important aspects of the patent document used in the enforcement of patent rights and the various aspects of enforcement.

Last date for enrollment is February 18, 2010.

Further Details:
http://www.wipo.int/academy/en/courses/distance_learning/catalog/c_index.html

Advanced Patent Drafting Workshop Being Organised by CII

Confederation of Indian Industry & Andhra Pradesh Technology Development and Promotion Center is organizing an

Advanced Patent Drafting Workshop on Patent Drafting & Technical Skills
(Better Training, Better Writing and Better Patents)
Date: 5-6 October 2009

Venue: National Academy of Agricultural Research Management Campus, Rajendra Nagar, Hyderabad 500 407

Fee Structure per delegate: Rs. 5000/-

India is growing in technology in leaps and bounds yet there exists a dearth of professionals who understand the dynamics involved in the field of Patent Drafting and Technical Writing Skills. To bridge this lacuna, APTDC under the aegis of CII is organizing an intense and comprehensive one and half day practical Patent Drafting is aimed and provides you cost effective and high quality patent writing skills development, patent specification drafting includes a written description of the invention, background, drawings, summary abstract of the disclosure, patent analysis, patent mapping and listing of claims conforming to the standards and requirements of an International application.


The Workshop will cover:
1) Improve your patent drafting skills.
2) Understand what drives the framing of critical drafting.
3) Acquire theoretical and practical skills related to patents and patent application procedures and to develop claim drafting skills.
4) The core skills to be imparted include scope of patent, patent application procedures, different types of claims, and claim drafting, in compliance with procedural requirements.

Who should attend?
1) Attending the workshop are scientists, researchers, technology managers, inventors, SME’s and attorneys with technical backgrounds, who will be drafting patent claims in the future.
2) This program is designed for private or corporate practitioners with patent experience who wish to improve their general claim drafting and amendment writing skills. Registrants will have the opportunity to concentrate on the specialized skilld required in their technological area.
3) Course material will include sample problems and model solutions.

Early registration is advisable as enrollment is limited.

Programme Schedule
(Each subject is 1 hour except as noted)
Day One, October 5, 2009

Review – Anatomy of a Patent

I. Goals for each section
II. General drafting strategy

Background – Multiple Theories

I. Purpose of the Background
a) Tell the story
b) Avoid Mistakes
II. Discussing prior art

Drafting for Clarity

I. The art of description
II. Claim construction
III. Ensuring that terms mean what you want them to mean

Drafting for Written Description

I. The Written Description Requirement
a) General
b) Chemical cases
c) Biotech cases.
II. Problem areas prosecution, continuations, priority cases
III. Identifying problems during drafting.

Drafting Enablement

I. The Enablement Requirement
II. Using the level of skill in the art
III. Enabling the full scope of the claims.
IV. Experimentation what is “undue”?

Day Two, October 6, 2009

Avoiding Drafting Pitfalls

I. “Patent Profanity”
II. Prosecution history.
III. “Last step before submission”
IV. Checklist

Claims – Scope and Coverage

I. Using Statutory classes
II. Varying claim scope
III. Claims and Specification developing scope.

Claims – Numbers and Relative Terms

I. Plural and singular
II. Claiming relative terms
IV. Functional claiming
V. Ranges

Claims – Preambles, Terms

I. Preamble as limitation.
II. Definiteness
III. Broadening with claim terms
IV. Broadening with spec terms

Claim Families

I. Identifying Potential infringers.
II. Drafting to cover all possible targets.
III. Using dependent claims
IV. Picket fences

Claims and Spec Together – Claim Interpretation (2 hour)

I. Claim construction Exercise
a) From both sides
b) Present arguments

For any queries, contact:
Kamaraju Chitrapy
Executive Officer – IPR
Confederation of Indian Industry
Andhra Pradesh Technology Development & Promotion Centre
1-11-252/9, Plot No:7 Regal house, II Floor,
Motilal Nehru Nagar, Begumpet, Hyderabad -500 016
Tel: 91-40277765837
Fax: 91-40-27765836
Mobile: 98492-39783
e-mail: c.kamaraju@cii.in
Website : http://www.aptdc.com